Anbio Biotechnology (NNNN) › RevenueAnbio Biotechnology (NNNN) — RevenueAnnual figures by fiscal year, from SEC filings.2022: $23.54M2023: $6.71M2024: $8.19M2025: $8.65M$8.65M2022Revenue (USD)2025Fiscal YearRevenueChange YoY2025$8.65M+5.6%2024$8.19M+21.9%2023$6.71M-71.5%2022$23.54M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share